Table 1.
Patient Characteristics
| Parameter | Newly diagnosed patients, numbers, or median (range), or percentages | Relapsed/refractory patients, numbers, or median (range) | |
|---|---|---|---|
| N | 156 | 47 | |
| Age (years) | 66 (32–94) | 63 (40–86) | |
| Male/female | 82/74 | 24/23 | |
| Albumin (g/l) | 38.0 (16.0–51.0) | 38.2 (24.8–48.0) | |
| β2‐microglobulin (mg/l) | 3.7 (1.1–85.9) | 3.5 (1.2–36.7) | |
| ISS stage | I | 59 | 20 |
| II | 63 | 17 | |
| III | 34 | 10 | |
| Isotype | IgG (IgGκ/IgGλ) | 100 (63/37) | 33 (14/19) |
| IgA (IgAκ/IgAλ) | 56 (33/23) | 14 (6/8) | |
| FISH (standard/high)a | 40/50 | 20/20 | |
| BMPC (%) | 40% (2–95%) | 25% (1–90%) | |
| Hemoglobin (g/dl) | 11.4 (4.6–16.7) | 11.3 (6.7–16.0) | |
| LDH (U/l) | 150.5 (36–1072) | 176.0 (68–746) | |
| Creatinine (mg/dl) | 1.1 (0.7–3.21) | 1.1 (0.6–4.8) | |
| Calcium (mg/dl) | 9.36 (7.28–12.84) | 9.08 (7.02–11.08) | |
| Follow‐up in months, median (range) | 45 (1–158) | 21 (3–33) | |
a
Available in 90 and 40 patients only.